Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Methylene Blue × 1 year × Clear all
NCT07435415 2026-02-27

Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

China Medical University Hospital

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00314405 2025-12-22

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

University Hospital, Strasbourg, France

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡